Cargando…

Evaluating the Protective Effect of Intravesical Bacillus Calmette-Guerin against SARS-CoV-2 in Non-Muscle Invasive Bladder Cancer Patients: A Multicenter Observational Trial

SIMPLE SUMMARY: The transurethral resection of bladder tumors followed by intravesical Bacillus Calmette-Guerin (BCG) instillations represents the standard treatment for high-risk and selected intermediate-risk non-muscle invasive bladder cancer (NMIBC) patients. We hypothesized that intravesical BC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hurle, Rodolfo, Soria, Francesco, Contieri, Roberto, Avolio, Pier Paolo, Mancon, Stefano, Lazzeri, Massimo, Bernasconi, Valentina, Mazzoli, Simone, Pizzuto, Giuseppe, De Bellis, Matteo, Rosazza, Matteo, Livoti, Simone, Lupia, Tommaso, Corcione, Silvia, Lillaz, Beatrice, De Rosa, Francesco Giuseppe, Buffi, Nicolò Maria, Kamat, Ashish M., Gontero, Paolo, Casale, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000457/ https://www.ncbi.nlm.nih.gov/pubmed/36900409 http://dx.doi.org/10.3390/cancers15051618

Ejemplares similares

Intravesical gemcitabine as bladder‐preserving treatment for BCG unresponsive non‐muscle‐invasive bladder cancer. Results from a single‐arm, open‐label study
por: Hurle, Rodolfo, et al.
Publicado: (2020)

Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?
por: D’Andrea, David, et al.
Publicado: (2019)

Clinical and pathological predictors of persistent T1 HG at second resection
por: Gobbo, Andrea, et al.
Publicado: (2023)

COVID-19 pandemic impact on uro-oncological disease outcomes at an Italian tertiary referral center
por: Oderda, Marco, et al.
Publicado: (2021)

Long-term Follow-up After En Bloc Transurethral Resection of Non–muscle-invasive Bladder Cancer: Results from a Single-center Experience
por: Paciotti, Marco, et al.
Publicado: (2021)

Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer
por: Lazzeri, Massimo, et al.
Publicado: (2022)

Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy
por: Ferro, Matteo, et al.
Publicado: (2022)

External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era
por: Frego, Nicola, et al.
Publicado: (2022)

Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study
por: Fasulo, Vittorio, et al.
Publicado: (2022)

Evaluation of Semen Self-Sampling Yield Predictors and CTC Isolation by Multi-Color Flow Cytometry for Liquid Biopsy of Localized Prostate Cancer
por: Saitta, Cesare, et al.
Publicado: (2023)

Safety and Feasibility of Salvage Endoscopic Combined Intrarenal Surgery in Embolized Kidney
por: Benincasa, Alfonso, et al.
Publicado: (2016)

New cephalosporins for the treatment of pneumonia in internal medicine wards
por: Lupia, Tommaso, et al.
Publicado: (2020)

Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
por: D’Andrea, David, et al.
Publicado: (2021)

Impact of systemic inflammatory markers on the response to Hyperthermic IntraVEsical Chemotherapy (HIVEC) in patients with non-muscle-invasive bladder cancer after bacillus Calmette–Guérin failure
por: Chiancone, Francesco, et al.
Publicado: (2021)

Penile tuberculosis following intravesical Bacille Calmette-Guérin immunotherapy
por: Chowdhury, Anadi Roy, et al.
Publicado: (2013)

Managing the adverse events of intravesical bacillus Calmette–Guérin therapy
por: Decaestecker, Karel, et al.
Publicado: (2015)

Tuberculous Spondylitis Caused by Intravesical Bacillus Calmette-Guerin Therapy
por: Minakata, Tomokazu, et al.
Publicado: (2020)

Reactive Arthritis After Intravesical Bacillus Calmette-Guérin Therapy
por: Taniguchi, Yoshinori, et al.
Publicado: (2022)

Outcomes and complications of Hyperthermic IntraVesical Chemotherapy using mitomycin C or epirubicin for patients with non-muscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure
por: Chiancone, Francesco, et al.
Publicado: (2020)

Post-Biopsy Cell-Free DNA From Blood: An Open Window on Primary Prostate Cancer Genetics and Biology
por: Corbetta, Marinella, et al.
Publicado: (2021)

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
por: Saban, Marcia R, et al.
Publicado: (2007)

Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy
por: Obaid, Sami, et al.
Publicado: (2011)

Morbilliform eruption in a patient receiving intravesical Bacilli Calmette-Guérin
por: Reid, Holly, et al.
Publicado: (2014)

Tuberculous Orchitis Following Intravesical Bacille Calmette-Guérin (BCG) Therapy
por: Klebanov, Nikolai, et al.
Publicado: (2018)

Disseminated Granulomatous Disease from Intravesical Instillation of Bacillus Calmette-Guerin
por: Ghafouri, Sayed Ab. Reshad, et al.
Publicado: (2018)

Tuberculosis epididymo-orchitis following intravesical bacillus Calmette-Guérin immunotherapy
por: Rezvani, Sean, et al.
Publicado: (2019)

Miliary Tuberculosis that Developed after Intravesical Bacillus Calmette-Guerin Therapy
por: Kaburaki, Kyohei, et al.
Publicado: (2017)

Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
por: Miyazaki, Masashi, et al.
Publicado: (2016)

Tuberculous prostatic abscess following intravesical bacillus Calmette-Guérin immunotherapy
por: Wang, Bin, et al.
Publicado: (2019)

Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review
por: Capelli, Laura, et al.
Publicado: (2016)

Assessing the Role of High-resolution Microultrasound Among Naïve Patients with Negative Multiparametric Magnetic Resonance Imaging and a Persistently High Suspicion of Prostate Cancer
por: Avolio, Pier Paolo, et al.
Publicado: (2022)

Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA‐repair genes
por: Fasulo, Vittorio, et al.
Publicado: (2023)

Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial
por: Contieri, Roberto, et al.
Publicado: (2022)

Antibiotic De-escalation Experience in the Setting of Emergency Department: A Retrospective, Observational Study
por: Corcione, Silvia, et al.
Publicado: (2021)

COVID-19: in the uncertainty, do not try this at home
por: Lupia, Tommaso, et al.
Publicado: (2020)

Novel Cephalosporins in Septic Subjects and Severe Infections: Present Findings and Future Perspective
por: Corcione, Silvia, et al.
Publicado: (2021)

Pityriasis Rosea-Like Rash Secondary to Intravesical Bacillus Calmette-Guerin Immunotherapy
por: Oh, Chee Won, et al.
Publicado: (2012)

Case report: Mycobacterium bovis orchitis post intravesical Bacillus Calmette Guerin
por: Samannodi, Mohammed, et al.
Publicado: (2018)

Evaluation of the Dwell-Time and Dose Difference in Intravesical Bacillus Calmette-Guèrin Therapy
por: Nagai, Takashi, et al.
Publicado: (2019)

A severe complication of intravesical bacillus Calmette-Guerin: An effect of different strains
por: Low, Li Sian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3vqrpdjq5qetd7om3q63hbse0j